News | September 28, 2024
Baxter launches nextgen airway clearance system
Developed in consultation with clinicians and patients for an enhanced user experience
Developed in consultation with clinicians and patients for an enhanced user experience
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by RSV in children at high risk for RSV disease
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Fermenta Biotech’s API manufacturing facility receives EU GMP compliance certificate
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
ALS patients experience neuroinflammation and rapid neurodegeneration
The partnership aims to revolutionize Artificial Intelligence in health research with innovative data platform
Agreement further expands Aptar Pharma’s leading respiratory portfolio
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug
Subscribe To Our Newsletter & Stay Updated
